A method and composition for the treatment, prevention and/or prophylaxis of a host, and in particular, a human, infected with Epstein-Barr virus (EBV), is provided that includes administering an effective amount of a 5-substituted uracil nucleoside or its pharmaceutically acceptable salt or prodrug, optionally in a pharmaceutically acceptable diluent or excipient.
提供了一种用于治疗、预防和/或预防寄主,特别是感染了爱泼斯坦-巴尔病毒(EBV)的人类的方法和组合物,包括向寄主施用有效量的5-取代尿
嘧啶核苷或其药学上可接受的盐或前药,可选地还包括药学上可接受的稀释剂或赋形剂。